{"id":1416,"date":"2026-06-29T11:53:33","date_gmt":"2026-06-29T11:53:33","guid":{"rendered":"https:\/\/www.arcgroup.io\/uxbridge\/?p=1416"},"modified":"2026-06-29T11:53:35","modified_gmt":"2026-06-29T11:53:35","slug":"parexel-launches-international-incubator","status":"publish","type":"post","link":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/","title":{"rendered":"Parexel launches international incubator\u00a0"},"content":{"rendered":"\n<!-- Back button -->\n<div class=\"back-button-block__container\">\n\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/community\/\" class=\"back-button-block\">\n\t\t<svg class=\"back-button-block__arrow\" width=\"13\" height=\"13\">\n\t\t\t<use xlink:href=\"#small-arrow\"><\/use>\n\t\t<\/svg>\n\t\tBack to Community\t<\/a>\n<\/div>\n\n\n\n<section class=\"feature-banner\" id=\"block_ef13e470e374b3c67f8e6aa00cfd1b0e\"> \n    <div class=\"feature-banner__container\">\n            <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg 550w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987-300x228.jpg 300w\" type=\"image\/jpeg\" sizes=\"(max-width: 768px) 768px, (max-width: 1024px) 1024px, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg\" \/>\n            <\/picture>\n\n    <\/div>\n<\/section>\n\n\n<h2 class=\"wp-block-post-title\">Parexel launches international incubator\u00a0<\/h2>\n\n\n    <ul class=\"ed-post-categories\">\n                    <li class=\"arc-orange\">\n                <a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/category\/news\/\">News<\/a>\n            <\/li>\n                    <li class=\"arc-purple\">\n                <a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/category\/corporate\/\">Corporate<\/a>\n            <\/li>\n            <\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative anchored at the company\u2019s Raleigh HQ. Open to all countries, it connects early-stage therapeutics companies with the clinical and regulatory expertise they need to advance their programs.&nbsp; The incubator launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm, and builds on Parexel\u2019s growing commitment to supporting early-stage innovation in collaboration with the venture community.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Parexel Biotech Incubator is designed to support emerging therapeutics companies at a stage when development strategy is still taking shape. Participating companies will have access to Parexel\u2019s clinical and regulatory expertise, including guidance on development planning, regulatory strategy and clinical trial design, alongside shared physical space that puts them in direct proximity to Parexel\u2019s Raleigh-based team and provides a collaborative home rather than resources and investment alone.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cReaching innovators at the earliest stages of their development journey, before clinical programs are formally structured, is where we can have the greatest impact. That is exactly what this initiative is designed to do,\u201d said Peyton Howell, Chief Executive Officer of Parexel. \u201cThe incubator reflects the evolution of our support for the biotech community, connecting seed-stage investment to clinical development expertise at the stage when it matters most. It builds on our broader commitment to investing in early-stage innovation alongside leading venture firms, and our inaugural partnership with Cape Fear BioCapital deepens our roots in one of the most dynamic life sciences ecosystems in the country.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The incubator builds on Parexel\u2019s broader commitment to investing in and fostering early-stage innovation alongside leading venture capital firms. Parexel has established collaborative relationships with leading venture firms as part of its strategy to advance and accelerate the next generation of therapeutics companies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership with Cape Fear BioCapital is designed to address a gap that early-stage therapeutics companies frequently face, where seed-stage investment and clinical development expertise rarely come together at the right time. Cape Fear BioCapital focuses on advancing companies from early discovery through IND-readiness, and the alliance creates a direct&nbsp;connection between its portfolio companies and Parexel\u2019s clinical and regulatory expertise at the stage when development decisions carry the most weight.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThe Parexel Biotech Incubator represents the next stage in Parexel Biotech\u2019s evolution and extends our long-standing commitment to the biotech community,\u201d said Jim Anthony, Chief Commercial Officer and President, Parexel Biotech. \u201cBy bringing our clinical and regulatory expertise to emerging innovators earlier in their development journeys, we can help companies make smarter development decisions, build stronger plans and position promising programs for lasting progress.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">North Carolina ranks seventh in the United States for life sciences employment, with more than 103,000 workers across nearly 6,700 establishments statewide. Anchored by Research Triangle Park, one of the world\u2019s largest research parks, the state is also home to leading research institutions including Duke University, the University of North Carolina at Chapel Hill&nbsp;and NC State University. Cape Fear BioCapital\u2019s deep ties to all three institutions reinforce the regional research pipeline helping shape North Carolina\u2019s next generation of therapeutics companies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cNorth Carolina has the scientific substrate, talent, and entrepreneurial ambition to build on our strong base of therapeutics innovation,&#8221; said Dave Ousterout, General Partner at Cape Fear BioCapital. &#8220;Working together with Parexel, we are dedicated to supporting emerging companies and connecting them with development expertise at a stage when strategic guidance can make a meaningful difference. Our partnership reflects a shared commitment to strengthening the support and capital available to innovators across the state.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>About the Parexel Biotech Incubator<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Parexel Biotech Incubator gives early-stage companies direct access to Parexel\u2019s clinical and regulatory expertise, reflecting Parexel\u2019s commitment to engaging biotech innovators earlier and building relationships that support future development needs. It is anchored at Parexel\u2019s North Hills Innovation District global headquarters in Raleigh, supporting emerging therapeutics companies wherever they are based.<\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n    <section class=\"news-archive \" id=\"block_8928a6798cf59da877bec7083c5c6428\">\n                    <div class=\"ed-container news-archive__title ed-archive-header__title ed-archive-header__title--large\">\n                <div class=\"ed-row\">\n                    <div class=\"ed-col ed-col__half\">\n                        \n                            <h3>More News<\/h3>\n                                            <\/div>\n                    <div class=\"ed-col ed-col__half\">\n                                                    <a href=\"https:\/\/www.arcgroup.io\/uxbridge\/community\/\" target=\"\">\n                                View all news &rarr;\n                            <\/a>\n                                            <\/div>\n                <\/div>\n            <\/div>\n                <div class=\"ed-container\">\n            <div class=\"ed-row\">\n                \n<article class=\"news-block ed-col ed-col__third\">\n\t<div class=\"news-block__inner\">\n\t\t<!-- Thumbnail -->\n\t\t<figure class=\"wp-block-post-featured-image\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/01\/19\/amgen-acquires-dark-blue-therapeutics-bolstering-oncology-pipeline\/\">\n\t\t\t\t    <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/211021-BLAST-Uxbridge-Business-Park-036-scaled.jpg 2560w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/211021-BLAST-Uxbridge-Business-Park-036-300x207.jpg 300w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/211021-BLAST-Uxbridge-Business-Park-036-1024x706.jpg 1024w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/211021-BLAST-Uxbridge-Business-Park-036-768x530.jpg 768w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/211021-BLAST-Uxbridge-Business-Park-036-1000x690.jpg 1000w\" type=\"image\/jpeg\" sizes=\"(min-width: 1200px) 34vw, (min-width: 768px) 50vw, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/211021-BLAST-Uxbridge-Business-Park-036-scaled.jpg\" \/>\n            <\/picture>\n\n\n\t\t\t\t<!-- Terms -->\n\t\t\t\t\t\t\t\t\t<div class=\"news-block__categories\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"arc-orange\">News<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/a>\n\t\t<\/figure>\n\n\t\t<!-- Title -->\n\t\t<div class=\"news-block__inner-title\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/01\/19\/amgen-acquires-dark-blue-therapeutics-bolstering-oncology-pipeline\/\" target=\"_self\">\n\t\t\t\tAmgen acquires Dark Blue Therapeutics, bolstering oncology pipeline\t\t\t<\/a>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n\n<article class=\"news-block ed-col ed-col__third\">\n\t<div class=\"news-block__inner\">\n\t\t<!-- Thumbnail -->\n\t\t<figure class=\"wp-block-post-featured-image\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2025\/07\/11\/arc-uxbridge-named-workspace-of-the-year-at-the-2025-hustle-awards\/\">\n\t\t\t\t    <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/08\/DSC07846-scaled-ezgif.com-webp-to-jpg-converter.jpg 2560w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/08\/DSC07846-scaled-ezgif.com-webp-to-jpg-converter-300x200.jpg 300w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/08\/DSC07846-scaled-ezgif.com-webp-to-jpg-converter-1024x683.jpg 1024w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/08\/DSC07846-scaled-ezgif.com-webp-to-jpg-converter-768x512.jpg 768w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/08\/DSC07846-scaled-ezgif.com-webp-to-jpg-converter-1000x667.jpg 1000w\" type=\"image\/jpeg\" sizes=\"(min-width: 1200px) 34vw, (min-width: 768px) 50vw, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/08\/DSC07846-scaled-ezgif.com-webp-to-jpg-converter.jpg\" \/>\n            <\/picture>\n\n\n\t\t\t\t<!-- Terms -->\n\t\t\t\t\t\t\t\t\t<div class=\"news-block__categories\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"arc-orange\">News<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/a>\n\t\t<\/figure>\n\n\t\t<!-- Title -->\n\t\t<div class=\"news-block__inner-title\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2025\/07\/11\/arc-uxbridge-named-workspace-of-the-year-at-the-2025-hustle-awards\/\" target=\"_self\">\n\t\t\t\tARC Uxbridge, named Workspace of the Year at the 2025 Hustle Awards\t\t\t<\/a>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n\n<article class=\"news-block ed-col ed-col__third\">\n\t<div class=\"news-block__inner\">\n\t\t<!-- Thumbnail -->\n\t\t<figure class=\"wp-block-post-featured-image\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2025\/03\/25\/arc-uxbridge-outperforms-5-year-average-uptake-for-the-area\/\">\n\t\t\t\t    <picture class=\"\">\n        <source srcset=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/ARC-Uxbridge-scaled.jpg 2560w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/ARC-Uxbridge-300x200.jpg 300w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/ARC-Uxbridge-1024x682.jpg 1024w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/ARC-Uxbridge-768x512.jpg 768w, https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/ARC-Uxbridge-1000x666.jpg 1000w\" type=\"image\/jpeg\" sizes=\"(min-width: 1200px) 34vw, (min-width: 768px) 50vw, 100vw\">\n        <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/03\/ARC-Uxbridge-scaled.jpg\" \/>\n            <\/picture>\n\n\n\t\t\t\t<!-- Terms -->\n\t\t\t\t\t\t\t\t\t<div class=\"news-block__categories\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"arc-orange\">News<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/a>\n\t\t<\/figure>\n\n\t\t<!-- Title -->\n\t\t<div class=\"news-block__inner-title\">\n\t\t\t<a href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2025\/03\/25\/arc-uxbridge-outperforms-5-year-average-uptake-for-the-area\/\" target=\"_self\">\n\t\t\t\tBrookfield&#8217;s ARC Uxbridge Campus Outperforms 5-year average uptake for the area following surge in high-profile leases\t\t\t<\/a>\n\t\t<\/div>\n\t<\/div>\n<\/article>\n            <\/div>\n        <\/div>\n    <\/section>\n","protected":false},"excerpt":{"rendered":"<p>Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative anchored at the company\u2019s Raleigh HQ. Open to all countries, it connects early-stage therapeutics companies with the clinical and regulatory expertise they need to advance their programs.&nbsp; The incubator launches alongside an inaugural partnership with Cape Fear BioCapital, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":1417,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[22,30],"tags":[4277,7228],"class_list":["post-1416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-corporate","tag-science-and-technology","tag-innovation"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Parexel launches international incubator\u00a0 - ARC Uxbridge<\/title>\n<meta name=\"description\" content=\"Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Parexel launches international incubator\u00a0 - ARC Uxbridge\" \/>\n<meta property=\"og:description\" content=\"Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\" \/>\n<meta property=\"og:site_name\" content=\"ARC Uxbridge\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T11:53:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T11:53:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"418\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"rebeccabethwaite\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rebeccabethwaite\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\"},\"author\":{\"name\":\"rebeccabethwaite\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/person\/3a1b3eb8a7bd2232ae3f80a34598bd57\"},\"headline\":\"Parexel launches international incubator\u00a0\",\"datePublished\":\"2026-06-29T11:53:33+00:00\",\"dateModified\":\"2026-06-29T11:53:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\"},\"wordCount\":659,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg\",\"keywords\":[\"Science and technology\",\"innovation\"],\"articleSection\":[\"News\",\"Corporate\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\",\"url\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\",\"name\":\"Parexel launches international incubator\u00a0 - ARC Uxbridge\",\"isPartOf\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg\",\"datePublished\":\"2026-06-29T11:53:33+00:00\",\"dateModified\":\"2026-06-29T11:53:35+00:00\",\"description\":\"Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage\",\"url\":\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg\",\"contentUrl\":\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg\",\"width\":550,\"height\":418},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arcgroup.io\/uxbridge\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Parexel launches international incubator\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#website\",\"url\":\"https:\/\/www.arcgroup.io\/uxbridge\/\",\"name\":\"ARC Uxbridge\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#organization\"},\"alternateName\":\"ARC Uxbridge\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arcgroup.io\/uxbridge\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#organization\",\"name\":\"ARC Uxbridge\",\"alternateName\":\"ARC Uxbridge\",\"url\":\"https:\/\/www.arcgroup.io\/uxbridge\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/06\/ARC-SUBBRANDS-LOGOS-03-UXBRIDGE-1.png\",\"contentUrl\":\"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/06\/ARC-SUBBRANDS-LOGOS-03-UXBRIDGE-1.png\",\"width\":2084,\"height\":2085,\"caption\":\"ARC Uxbridge\"},\"image\":{\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/person\/3a1b3eb8a7bd2232ae3f80a34598bd57\",\"name\":\"rebeccabethwaite\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1ee39d695ce12a74184723b0a62162c291da18c1d7878213e161c04e87289ce2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1ee39d695ce12a74184723b0a62162c291da18c1d7878213e161c04e87289ce2?s=96&d=mm&r=g\",\"caption\":\"rebeccabethwaite\"},\"url\":\"https:\/\/www.arcgroup.io\/uxbridge\/blog\/author\/rebeccafrost\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Parexel launches international incubator\u00a0 - ARC Uxbridge","description":"Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/","og_locale":"en_US","og_type":"article","og_title":"Parexel launches international incubator\u00a0 - ARC Uxbridge","og_description":"Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative.","og_url":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/","og_site_name":"ARC Uxbridge","article_published_time":"2026-06-29T11:53:33+00:00","article_modified_time":"2026-06-29T11:53:35+00:00","og_image":[{"width":550,"height":418,"url":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg","type":"image\/jpeg"}],"author":"rebeccabethwaite","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rebeccabethwaite","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#article","isPartOf":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/"},"author":{"name":"rebeccabethwaite","@id":"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/person\/3a1b3eb8a7bd2232ae3f80a34598bd57"},"headline":"Parexel launches international incubator\u00a0","datePublished":"2026-06-29T11:53:33+00:00","dateModified":"2026-06-29T11:53:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/"},"wordCount":659,"commentCount":0,"publisher":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/#organization"},"image":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg","keywords":["Science and technology","innovation"],"articleSection":["News","Corporate"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/","url":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/","name":"Parexel launches international incubator\u00a0 - ARC Uxbridge","isPartOf":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage"},"image":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg","datePublished":"2026-06-29T11:53:33+00:00","dateModified":"2026-06-29T11:53:35+00:00","description":"Uxbridge and US-based Parexel, a global clinical development partner, has launched Parexel Biotech Incubator, an international initiative.","breadcrumb":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#primaryimage","url":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg","contentUrl":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2026\/06\/6153-paraxel-1-5987.jpg","width":550,"height":418},{"@type":"BreadcrumbList","@id":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/2026\/06\/29\/parexel-launches-international-incubator\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arcgroup.io\/uxbridge\/"},{"@type":"ListItem","position":2,"name":"Parexel launches international incubator\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.arcgroup.io\/uxbridge\/#website","url":"https:\/\/www.arcgroup.io\/uxbridge\/","name":"ARC Uxbridge","description":"","publisher":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/#organization"},"alternateName":"ARC Uxbridge","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arcgroup.io\/uxbridge\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arcgroup.io\/uxbridge\/#organization","name":"ARC Uxbridge","alternateName":"ARC Uxbridge","url":"https:\/\/www.arcgroup.io\/uxbridge\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/logo\/image\/","url":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/06\/ARC-SUBBRANDS-LOGOS-03-UXBRIDGE-1.png","contentUrl":"https:\/\/www.arcgroup.io\/uxbridge\/wp-content\/uploads\/sites\/3\/2025\/06\/ARC-SUBBRANDS-LOGOS-03-UXBRIDGE-1.png","width":2084,"height":2085,"caption":"ARC Uxbridge"},"image":{"@id":"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/person\/3a1b3eb8a7bd2232ae3f80a34598bd57","name":"rebeccabethwaite","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arcgroup.io\/uxbridge\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1ee39d695ce12a74184723b0a62162c291da18c1d7878213e161c04e87289ce2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ee39d695ce12a74184723b0a62162c291da18c1d7878213e161c04e87289ce2?s=96&d=mm&r=g","caption":"rebeccabethwaite"},"url":"https:\/\/www.arcgroup.io\/uxbridge\/blog\/author\/rebeccafrost\/"}]}},"_links":{"self":[{"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/posts\/1416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/comments?post=1416"}],"version-history":[{"count":1,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/posts\/1416\/revisions"}],"predecessor-version":[{"id":1418,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/posts\/1416\/revisions\/1418"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/media\/1417"}],"wp:attachment":[{"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/media?parent=1416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/categories?post=1416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arcgroup.io\/uxbridge\/wp-json\/wp\/v2\/tags?post=1416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}